Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20250929005) titled 'Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV-HAT)' on Sept. 29.

Study Type: Observational

Primary Sponsor: GlaxoSmithKline (Thailand) Limited

Condition: RSV infection in Adult 18+ Respiratory Syncytial Virus, Thailand, Hospitalization, Health Care Utilization Respiratory Syncytial Virus, Thailand, Hospitalization, Health Care Utilization

Intervention: Adult RSV-related hospitalization 18 year and above Other

Recruitment Status: Not Recruiting

Date of First Enrollment: 01/06/2016

Target Sample Size: 626

Countries of Recruitme...